Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Stock Price Down 0.2%

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ)’s stock price traded down 0.2% during mid-day trading on Friday . The company traded as low as $6.12 and last traded at $6.19. 67,239 shares changed hands during mid-day trading, a decline of 67% from the average session volume of 205,918 shares. The stock had previously closed at $6.20.

Health Sciences Acquisitions Co. 2 Price Performance

The business’s fifty day moving average is $6.60 and its two-hundred day moving average is $11.95.

Hedge Funds Weigh In On Health Sciences Acquisitions Co. 2

Several large investors have recently modified their holdings of HSAQ. PenderFund Capital Management Ltd. purchased a new stake in shares of Health Sciences Acquisitions Co. 2 in the fourth quarter valued at $748,000. RPO LLC raised its position in Health Sciences Acquisitions Co. 2 by 14.7% in the 4th quarter. RPO LLC now owns 27,755 shares of the company’s stock worth $277,000 after purchasing an additional 3,554 shares during the period. Saba Capital Management L.P. bought a new stake in Health Sciences Acquisitions Co. 2 in the first quarter worth about $7,309,000. Sculptor Capital LP purchased a new position in shares of Health Sciences Acquisitions Co. 2 during the first quarter valued at approximately $4,868,000. Finally, Radcliffe Capital Management L.P. bought a new position in shares of Health Sciences Acquisitions Co. 2 during the first quarter valued at approximately $4,036,000. Institutional investors own 89.71% of the company’s stock.

About Health Sciences Acquisitions Co. 2

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe.